Clinical Trial Program
Oncology (Broad)
N/A (Diagnostic Validation)Active
Key Facts
About VitroScan
VitroScan is a private, late-stage diagnostics company leveraging a proprietary ex vivo micro-tumor platform to advance precision oncology. Its core offering is a predictive testing service that uses patient-derived 3D micro-tumors to model treatment responses, aiming to improve clinical outcomes for cancer patients and reduce late-stage failures in drug development. The company has achieved ISO 15189 accreditation for its quality management system and is actively engaged in clinical trials to further validate its platform. With a team of experts in oncology and bioinformatics, VitroScan is positioned at the intersection of diagnostics and translational drug development support.
View full company profileTherapeutic Areas
Other Oncology (Broad) Drugs
| Drug | Company | Phase |
|---|---|---|
| Functional Precision Oncology Platform Validation | Known Medicine | Pre-clinical |
| Personalized Treatment Screening | Okomera | Pre-clinical |
| Preclinical Drug Discovery Services | Okomera | Pre-clinical |
| RWE Data Pipeline | Perthera | Commercial |
| Clinical Trial Matching Service | Perthera | Commercial |
| Enhanced Liquid Biopsy Platform | Wobble Genomics | Platform Validation |
| Live Tissue Biobanking Service | SpeciCare | Service |
| Ex Vivo Therapy Testing | SpeciCare | Research |
| Personalized Vaccine Support | SpeciCare | Research |
| Clinical Trial Matching & Access | SpeciCare | Service |
| Organoid Creation & Biobanking | SpeciCare | Research |